Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults

Vendrell, 2008, Diagnóstico y tratamiento de las bronquiectasias, Arch Bronconeumol, 44, 629, 10.1157/13128330 Seitz, 2012, Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007, Chest, 142, 432, 10.1378/chest.11-2209 De la Rosa, 2016, Annual direct medical costs of bronchiectasis treatment: impact of severity, exacerbations, chronic bronchial colonization and chronic obstructive pulmonary disease coexistence, Chron Respir Dis, 10.1177/1479972316643698 Fuschillo, 2008, Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms, Eur Respir J, 31, 396, 10.1183/09031936.00069007 Cole, 1986, Inflammation: a two-edged sword – the model of bronchiectasis, Eur J Respir Dis Suppl, 147, 6 Gao, 2016, Aetiology of bronchiectasis in adults: a systematic literature review, Respirology, 21, 1376, 10.1111/resp.12832 Lonni, 2015, Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity, Ann Am Thorac Soc, 12, 1764, 10.1513/AnnalsATS.201507-472OC Olveira, 2017, Etiology of bronchiectasis in a cohort of 2047 patients. An analysis of the Spanish Historical Bronchiectasis Registry, Arch Bronconeumol, 53, 366, 10.1016/j.arbres.2016.12.003 Martínez-García, 2010, EPOC y bronquiectasias, Arch Bronconeumol, 46, 11, 10.1016/S0300-2896(10)70021-1 Martínez-García, 2013, Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 187, 823, 10.1164/rccm.201208-1518OC Paganin, 1996, Computed tomography of the lungs in asthma: influence of disease severity and etiology, Am J Respir Crit Care Med, 153, 110, 10.1164/ajrccm.153.1.8542102 Murray, 2009, Sputum color: a useful clinical tool in non-cystic fibrosis bronchiectasis, Eur Resp J, 34, 361, 10.1183/09031936.00163208 Olveira, 2014, Validation of a quality of life questionnaire for bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0, Qual Life Res, 23, 1279, 10.1007/s11136-013-0560-0 Martínez García, 2005, Internal consistency and validity of the Spanish version of the St George's respiratory questionnaire for use in patients with clinically stable bronchiectasis, Arch Bronconeumol, 41, 110, 10.1157/13071580 Muñoz, 2016, Validation of a Spanish version of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis, Chron Respir Dis, 13, 128, 10.1177/1479972316632005 Webb, 2000, Airways diseases, 467 De Gracia, 1996, IgG subclass deficiencies associated with bronchiectasis, Am J Respir Crit Care Med, 153, 650, 10.1164/ajrccm.153.2.8564113 Cantón, 2015, Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients, Arch Bronconeumol, 51, 140, 10.1016/j.arbres.2014.09.021 Chalmers, 2012, Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis, Am J Respir Crit Care Med, 186, 657, 10.1164/rccm.201203-0487OC Reiff, 2011, CT findings in bronchiectasis: limited value in distinguishing between, Eur Respir Mon, 52, 44 Bhalla, 1991, Cystic fibrosis: scoring system with thin-section CT, Radiology, 179, 783, 10.1148/radiology.179.3.2027992 Martínez-García, 2014, Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score, Eur Respir J, 43, 1357, 10.1183/09031936.00026313 Chalmers, 2014, The bronchiectasis severity index. An international derivation and validation study, Am J Respir Crit Care Med, 189, 576, 10.1164/rccm.201309-1575OC Martinez-Garcia, 2017, Predicting high risk of exacerbations in bronchiectasis: the E-FACED score, Int J Chron Obstruct Pulmon Dis, 12, 275, 10.2147/COPD.S121943 Martínez-García, 2007, Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis, Chest, 132, 1565, 10.1378/chest.07-0490